Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

FBRX stock hub

Forte Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FBRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

609.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

FBRX

In the news

Latest news · FBRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-122.3

P25 -105.6P50 -46.5P75 -3.1

ROIC-77.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FBRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001419041
Company name	Forte Biosciences, Inc.
Country	United States
Country code	US
Cusip	34962G109
Employees	19
Employees Change	5%
Employees Change Percent	35.71
Enterprise value	$532.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US34962G2084
Last refreshed	2026-05-10
Market cap	$609.2M
Market cap category	Small-Cap
Price	$24.02
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	FBRX
Website	https://www.fortebiorx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-11.39%
FCF yield	-8.37%
P/B ratio	7.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-69.4M
Net Income Growth Years	0%
Profit Per Employee	$-3.7M
ROA	-61.19
Roa5y	-40.58
ROCE	-113.9
ROE	-122.3
Roe5y	-73.15
ROIC	-77.84

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	288.41%
Cagr3y	-2.92%
Cagr5y	-50.6%
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$82.8M
Cash	$77M
Current Assets	$80.6M
Current Liabilities	$20.8M
Equity	$61M
Liabilities	$21.8M
Long Term Assets	$2.2M
Long Term Liabilities	$1M
Net Cash	$77M
Net Cash By Market Cap	$12.63
Net Cash Growth	31.85%
Net Debt Equity	$-1.26
Tangible Book Value	$61M
Tangible Book Value Per Share	$3.42
WACC	20.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.88
Net Working Capital	$-17.1M
Quick ratio	3.75
Working Capital	$59.8M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-404.74%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	288.05%
200-day SMA	21.08
3Y total return	-8.5%
50-day SMA	28.18
50-day SMA vs 200-day SMA	50over200
5Y total return	-97.06%
All Time High	1,349.8
All Time High Change	-98.22%
All Time High Date	2020-09-24
All Time Low	4.11
All Time Low Change	484.43%
All Time Low Date	2024-11-01
ATR	2.5
Beta	3
Beta1y	1.03
Beta2y	1.67
Ch YTD	-11.92
High	25.97
High52	35.8
High52 Date	2026-04-09
High52ch	-32.91%
Low	23.53
Low52	6.19
Low52 Date	2025-05-08
Low52ch	288.05%
Ma50ch	-14.75%
Price vs 200-day SMA	13.93%
RSI	37.78
RSI Monthly	49.13
RSI Weekly	48.45
Sharpe ratio	1.73x
Sortino ratio	3.01
Total Return	-404.74%
Tr YTD	-11.92
Tr1m	-8.22%
Tr1w	-14.79%
Tr3m	-12.94%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$68
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.11
Operating Income	$-70.7M
Price target	$67
Price Target Change	$179
Price Target Change Top	$183

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18,592,247%
Float Percent	73.31%
Shares Insiders	1.74%
Shares Institutions	49.57%
Shares Out	25,361,432
Shares Qo Q	0.39%
Shares Yo Y	404.74%
Short Float	4.54%
Short Ratio	2.09
Short Shares	3.33

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-57.3M
Average Volume	240,324.75x
Bv Per Share	3.42
CAPEX	$-116,000
Ch1m	-8.22
Ch1w	-14.79
Ch1y	288
Ch3m	-12.94
Ch3y	-8.5
Ch5y	-97.06
Ch6m	98.84
Change	-8.22%
Change From Open	-7.44
Close	26.17
Days Gap	-0.84
Depreciation Amortization	64,000
Dollar Volume	8,281,711.7
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-70.7M
EBITDA	$-70.6M
EPS	$-4.71
F Score	1
FCF	$-51M
FCF EV Yield	-9.58x
FCF Per Share	$-2.01
Financing CF	69,361,000
Fiscal Year End	December
Income Tax	$1M
Investing CF	36,234,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2024-08-28
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	24.21
Ma150ch	-0.78%
Ma20	29.08
Ma20ch	-17.41%
Net CF	54,713,000
Next Earnings Date	2026-05-22
Open	25.95
Optionable	Yes
Position In Range	20.08
Post Close	24.02
Postmarket Change Percent	-2.58
Postmarket Price	$23.4
Ppne	129,000
Price Date	2026-05-08
Ptbv Ratio	9.99
Relative Volume	1.43x
Share Based Comp	6,258,000
Tr6m	98.84%
Us State	Texas
Volume	344,784

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FBRX pay a dividend?

Capital-return profile for this ticker.

Performance

FBRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FBRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+49.6%

Float: +73.3% of shares outstanding

Insider ownership

+1.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FBRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.8

Neutral momentum band

Price vs 200-day MA

+13.9%

50/200-day relationship not available

Beta (5Y)

3.00

More volatile than the market

Sharpe ratio

1.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FBRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current FBRX stock rating?

Forte Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full FBRX analysis?

The full report lives at /stocks/FBRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for FBRX?

The latest report frames FBRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the FBRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.